MakingDiagnosticsReadily Available
Rapid molecular testing for infectious disease: no instruments, no electricity, results in 30 minutes.
At a Glance
Partners and Collaborators
Rapid diagnostics, reliable results.
Easy to use when and where needed. Our technology delivers accurate YES/NO results about ongoing infections in just 15–30 minutes, without any instrumentation.
Reliable
Molecular-level accuracy without laboratory infrastructure. Get a clear YES or NO answer on active infection at the bedside, the clinic, or the field.
Fast
From sample to result in 15–30 minutes. Fast enough to inform treatment decisions before the patient leaves.
Affordable
No instruments. No cold chain. No specialist training required. Our platform removes the cost barriers that keep diagnostics out of reach.
Scalable
The same padlock probe platform adapts to new pathogens without redesigning the system. One platform, any infectious target.
Advanced Diagnostics for Everyone.
Science-driven Origins
Built on a key invention by Dr Liza Löf that compresses complex molecular detection into a single 30-minute reaction with no lab needed.
A Committed Team
Our team combines deep academic expertise with industrial experience. Scientists, engineers and innovators committed to improving global health.
Our Values & Purpose
Diagnostics should be rapid, accessible and reliable for everyone. Guided by scientific integrity and commitment to patient care worldwide.
Point-of-Care Testing
Implemented in a device for a 30-minute reaction at point of care. No laboratory infrastructure needed, results where and when they matter most.
Multi, single plex detection
Readily's padlock probe based technology is easily adapted to new target variants. Test for multiple pathogens simultaneously with a single sample.
Our Leadership & Vision.
“We built Readily because the gap between laboratory science and clinical reality is still enormous. Molecular diagnostics should not require a hospital lab. We are changing that.”
Liza Löf
CEO & Founder, Readily Diagnostics“We are proud to be part of this dedicated investor consortium of valued local partners that will allow Readily to take the next necessary steps of developing the production capacity to enable a market introduction.”
Gunilla Lundmark
Uppsala University Invest's CEOWant to learn more about the people driving Readily?
Meeting a Global Need
As we all witnessed during the Covid-19 pandemic, there is a need for more accessible, easy-to-use and reliable diagnostic tests.
The United Nations Sustainability Goal No. 3 for 2030 calls for Good Health and Well-Being for everyone, but nearly half the world's population lacks access to basic infection diagnostics.
We aim to change the diagnostic landscape globally with our rapid diagnostic tests offering the performance of RT-PCR, but with no need for instrumentation.
of the world's population lacks access to basic infection diagnostics
